Követés
Tamás Csonka
Tamás Csonka
Institute of Pathology, University of Debrecen, Faculty of Medicine
E-mail megerősítve itt: med.unideb.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Red cells, hemoglobin, heme, iron, and atherogenesis
E Nagy, JW Eaton, V Jeney, MP Soares, Z Varga, Z Galajda, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (7), 1347-1353, 2010
2522010
Microbiome—microbial metabolome—cancer cell interactions in breast cancer—familiar, but unexplored
E Mikó, T Kovács, É Sebő, J Tóth, T Csonka, G Ujlaki, A Sipos, J Szabó, ...
Cells 8 (4), 293, 2019
1502019
Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness
E Mikó, A Vida, T Kovács, G Ujlaki, G Trencsényi, J Márton, Z Sári, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1859 (9), 958-974, 2018
1462018
Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors
T Kovács, E Mikó, A Vida, É Sebő, J Toth, T Csonka, A Boratkó, G Ujlaki, ...
Scientific reports 9 (1), 1300, 2019
1412019
The age and genomic integrity of neurons after cortical stroke in humans
HB Huttner, O Bergmann, M Salehpour, A Rácz, J Tatarishvili, E Lindgren, ...
Nature neuroscience 17 (6), 801-803, 2014
1352014
Lithocholic acid, a metabolite of the microbiome, increases oxidative stress in breast cancer
P Kovács, T Csonka, T Kovács, Z Sári, G Ujlaki, A Sipos, Z Karányi, ...
Cancers 11 (9), 1255, 2019
782019
Indolepropionic acid, a metabolite of the microbiome, has cytostatic properties in breast cancer by activating AHR and PXR receptors and inducing oxidative stress
Z Sári, E Mikó, T Kovács, L Jankó, T Csonka, G Lente, É Sebő, J Tóth, ...
Cancers 12 (9), 2411, 2020
762020
Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence
T Csonka, B Murnyák, R Szepesi, J Bencze, L Bognár, Á Klekner, ...
Folia Neuropathologica 54 (2), 114-126, 2016
332016
Poly (ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas
T Csonka, B Murnyák, R Szepesi, A Kurucz, Á Klekner, T Hortobágyi
Folia Neuropathologica 52 (2), 111-120, 2014
282014
Occurrence and molecular pathology of high grade gliomas
B Murnyák, T Csonka, K Hegyi, G Méhes, A Klekner, T Hortobágyi
Ideggyogyaszati Szemle 66 (9-10), 312-321, 2013
17*2013
Primary angiosarcoma of the pancreas mimicking severe acute pancreatitis–case report
A Csiszkó, I László, K Palatka, KG Szabó, Z Kanyári, L Bidiga, T Csonka, ...
Pancreatology 15 (1), 84-87, 2015
162015
The diagnosis of herpes encephalitis--a case-based update
T Csonka, R Szepesi, L Bidiga, M Péter, A Klekner, G Hutóczky, L Csiba, ...
Ideggyogyaszati Szemle 66 (9-10), 337-342, 2013
132013
Fecal expression of Escherichia coli lysine decarboxylase (LdcC) is downregulated in E-cadherin negative lobular breast carcinoma
Z Sári, T Kovács, T Csonka, M Török, É Sebő, J Tóth, D Tóth, E Mikó, ...
Physiology International 107 (2), 349-358, 2020
112020
Molecular pathology of meningiomas
B Murnyak, T Csonka, T Hortobagyi
Ideggyogyaszati Szemle 68 (9-10), 292-300, 2015
112015
Occurrence and molecular pathology of low grade gliomas
B Murnyák, T Csonka, A Klekner, T Hortobágyi
Ideggyogyaszati Szemle 66 (9-10), 305-311, 2013
72013
Primary uterine NK-cell lymphoma, nasal-type: a unique malignancy of a prominent cell type of the endometrium
G Méhes, K Hegyi, T Csonka, F Fazakas, Z Kocsis, G Radványi, I Vadnay, ...
Pathology & Oncology Research 18, 519-522, 2012
72012
Inclusion body myositis–pathomechanism and lessons from genetics
B Murnyák, L Bodoki, M Vincze, Z Griger, T Csonka, R Szepesi, A Kurucz, ...
Open Medicine 10 (1), 2015
62015
Inclusion body myositis
L Bodoki, M Vincze, Z Griger, T Csonka, K Dankó, T Hortobágyi
Ideggyogyaszati Szemle 68 (1-2), 59-67, 2015
52015
Anti-signal recognition particle autoantibody positive myopathy
L Bodoki, M Vincze, T Hortobágyi, Z Griger, T Csonka, K Danko
Ideggyogyaszati Szemle 67 (9-10), 347-353, 2014
42014
The role of carbonic anhydrase IX in the progression of malignant tumors-a potential therapeutic target?
O Matolay, SE Bádon, L Balázs, P Juhász, T Csonka, G Méhes
Magyar Onkologia 65 (2), 157-166, 2021
32021
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20